GEP20002136B - Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow - Google Patents

Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow

Info

Publication number
GEP20002136B
GEP20002136B GEAP19984513A GEAP1998004513A GEP20002136B GE P20002136 B GEP20002136 B GE P20002136B GE AP19984513 A GEAP19984513 A GE AP19984513A GE AP1998004513 A GEAP1998004513 A GE AP1998004513A GE P20002136 B GEP20002136 B GE P20002136B
Authority
GE
Georgia
Prior art keywords
bone marrow
diagnosis
hemoblastosis
metastases
malignant tumor
Prior art date
Application number
GEAP19984513A
Inventor
Tinatin Shvelidze
Tamar Saralidze
Original Assignee
Tinatin Shvelidze
Tamar Saralidze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tinatin Shvelidze, Tamar Saralidze filed Critical Tinatin Shvelidze
Priority to GEAP19984513A priority Critical patent/GEP20002136B/en
Publication of GEP20002136B publication Critical patent/GEP20002136B/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1. Technical Result Simplification of method and increase in diagnosis accuracy. 2. Essence Cells of bone marrow and/or leukocyte of peripheric blood are cultivated on donor blood plasma at ratio 1:3 and blastic cells are revealed. For determining of the diagnose revealing of 5-10% blastic cells, at existence of their mitosis form, is sufficient. 3. Field of Application Medicine, hematology, oncology.
GEAP19984513A 1998-10-05 1998-10-05 Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow GEP20002136B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP19984513A GEP20002136B (en) 1998-10-05 1998-10-05 Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP19984513A GEP20002136B (en) 1998-10-05 1998-10-05 Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow

Publications (1)

Publication Number Publication Date
GEP20002136B true GEP20002136B (en) 2000-06-25

Family

ID=82786938

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19984513A GEP20002136B (en) 1998-10-05 1998-10-05 Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow

Country Status (1)

Country Link
GE (1) GEP20002136B (en)

Similar Documents

Publication Publication Date Title
Fournel-Fleury et al. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen
Yeatman et al. Molecular basis of tumor progression: mechanisms of organ‐specific tumor metastasis
Thompson et al. Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1, 3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer
Morton et al. Critical review of the sentinel node hypothesis
Cain et al. Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment
GEP20002136B (en) Method for Diagnosis of Malignant Tumor Hemoblastosis and Metastases in Bone Marrow
Oka et al. Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers
Wu et al. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma
Fosså et al. DNA flow cytometry in human testicular cancer
Vinciguerra et al. The importance of bone marrow biopsy in the staging of patients with lymphosarcoma
Matsuzuka et al. Attempting to define sentinel node micrometastasis in oral squamous cell carcinoma
Silvestrini et al. Cell kinetics: a prognostic marker in epithelial ovarian cancer
Nejmeddine et al. MECHANISM INVOLVED IN GALLIUM-67 (Ga-67) UP TAKE
Khan et al. In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonic mucosa using intravenous infusions of bromodeoxyuridine
Kolodziejski et al. Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer
Resnik et al. Long‐term survival and DNA ploidy in advanced epithelial ovarian cancer
Freiha et al. Selection criteria for radical prostatectomy based on morphometric studies in prostate carcinoma
Madersbacher et al. TPS in prostate cancer
Mori et al. Papillary adenocarcinoma of the subvesical duct
Miller Prognostic factors in breast cancer
Nakata et al. Decreased monocyte-mediated cytostasis of human cancer cell in patients with lung cancer
Vassallo et al. Eosinophilic folliculitis occurring in a patient affected by Hodgkin lymphoma
Rosen Placental isoferritin-associated p43 in pregnancy and breast cancer. Minireview
Yaghmour et al. Merkel Cell Carcinoma Brain Metastasis Mimicking Stroke: A Case Report
Adeyinka et al. A subgroup of breast carcinomas is cytogenetically characterized by trisomy 12